in eye News
-
Showcase
Mojo Vision Reaches Significant Development Milestone for Smart Contact Lens
New prototype of Mojo Lens incorporates numerous industry-first features, including the world’s smallest and densest dynamic display, low-latency communication, and an eye-controlled user interface SARATOGA, Calif.--(March 30, 2022)--Mojo Vision, the Invisible Computing Company, today announced its most advanced prototype of Mojo Lens, the world's first true smart contact lens, including ...
-
Mitigating Ocular Infection Risks in the Workplace and the Importance of Eye Protection
Each year, thousands of employees are blinded from work-related eye injuries that could have been prevented with the proper selection and use of eye and face protection according to the Occupational Safety and Health Administration (OSHA). OSHA standards require employers to ensure the safety of all employees in the work environment and this includes eye and face protection. This must be provided ...
-
Eye on Earth First User Conference: A real eye opener
The city of Dublin was the setting for the first Eye on Earth User Conference, organised by the European Environment Agency (EEA) in association with the Irish Presidency of the Council of the European Union. Over three days (4-6 March), the conference brought together more than 230 participants representing communities in 77 countries. They exchanged views and ideas on how to expand the Eye on ...
-
To The Point About Preventing Eye Injuries
Dust, wood chips, nails, hazardous chemicals, radiant light and countless other items can strike or enter the eye and cause injury. Taking proper precautions and wearing the appropriate protection against eye hazards can prevent eye injuries. This program provides an overview of your organization’s plan to protect your sight and points out how the use of various protective devices can ...
-
See Far third Plenary Meeting in Ioannina (Greece)
Moving the entire consortium toward Ioannina was a real adventure as some of us travelled two days and waited hours for the connecting flight. It was not the very surprising when we met all partners in front of the same gate for Ioannina to take the only plane we could take. We had a great time, discussing on key issues and work packages to be delivered in ...
By D-EYE Srl
-
D-EYE in the European Deep Tech Landscape for 2019
D-EYE is one of the most promising Deep-Tech startups & scale-ups in Europe, according to TNW X and EIT Digital. TNW X and EIT Digital made a strict selection of 200 of the most promising startups and scale-ups in Europe. We are proud to be included in this prestigous chart among other important business realities and looking forward to meet more companies. ...
By D-EYE Srl
-
Web Summit 2019: D-EYE and See Far
With more than 70,000 attendees from 160 countries and +2500 journalists, the Web Summit is considered one of the most important technology conferences in the world. D-EYE attended this three-day tech event with a booth in the Alpha program of the Web Summit. During the conference, D-EYE presented the See Far solution to the participants, companies and organization visiting the booth. The See ...
By D-EYE Srl
-
See Far Second Plenary Meeting
D-EYE is one of the 12 partners of the See Far Project. The second plenary meeting took place in the hospital Clínica Nuestra Señora de La Paz, belonging to one of the partners of the consortium (OHSJD). The partners presented the main outcomes from the work packages so far, discussed and agreed on the most relevant questions, worked together on specific topics, made a general ...
By D-EYE Srl
-
D-EYE to attend CES 2020
The Consumer Electronics Show, or CES, is one of the biggest tech events of the year, where companies from around the world gather to announce new gadgets and showcase their products. D-EYE will showcase its smartphone-based digital ophthalmoscope and the D-EYE Cloud for telemedicine management. The company will be part of the Italian Trade Agency commitee at booth n. 52722. We can't wait to ...
By D-EYE Srl
-
MediPrint™ Ophthalmics Announces Promising Results From Its Primary Market Research
SAN DIEGO–(BUSINESS WIRE)–Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces enlightening findings from its primary market research with optometrists and ophthalmologists related to contact lens drug delivery and its proprietary pipeline of assets. Key learnings from the market ...
-
See Far Update: 1° hardware bench prototype integration exercise
In the 3° Plenary Meeting of the See Far project, held in Ioannina (Greece) on the 16-17 January 2020, one of the most important sessions of the meeting was that dedicated to bringing together ‘physically’, for the 1st time, some of the key hardware components of the overall solution, with the aim to identify related interoperability/integration difficulties and to draw important ...
By D-EYE Srl
-
The Medical Futurist About the D-EYE Digital Ophthalmoscope
The Medical Futurist works for making a bold vision about the future of healthcare reality today. In its latest article, the team with the help of Dr. Cserháti tested and reviewed the D-EYE Digital Ophthalmoscope. "It’s a winner when it comes to examining fidgety children and disabled patients. Furthermore, in the time of a pandemic, not being right up another person’s face is ...
By D-EYE Srl
-
Optos wins Artificial Intelligence in Health and Care Award to support the early detection of diabetes in NHS patients
Optos, a Fife based company and a world-leader in the design and manufacturing of advanced retinal imaging technology, has been awarded NHS funding to accelerate the implementation and validation of Artificial Intelligence (AI) to support the early detection of Diabetes related eye-disease into NHS Diabetic Eye Screening practices. The technology uses a machine learning algorithm to analyse ...
By Optos, Inc.
-
FDA approves first artificial iris
The U.S. Food and Drug Administration has announced its approval of the first stand-alone prosthetic iris in the United States that could help patients with certain types of eye damage see clearly and improve their appearance. The surgically implanted device, called the CustomFlex Artificial Iris, is meant to treat adults and children whose iris — the part of the eye that is colored around ...
-
Agilent Technologies names Massachusetts Eye and Ear Infirmary as Certified Service Provider for Next-Generation Sequencing and aCGH Solutions
Agilent Technologies Inc. (NYSE: A) today announced that the Massachusetts Eye and Ear Infirmary, an affiliate of Harvard Medical School, has been authorized as a Certified Service Provider of Agilent's next-generation target enrichment and microarray-based comparative genomic hybridization (aCGH) solutions. MEEI is home to the medical school's Department of Ophthalmology Ocular Genomics ...
-
Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent
SPECTRUM, the world’s largest single-device registry in ophthalmology, has completed enrollment. The announcement was made today by Ivantis Inc., a company dedicated to developing new and innovative solutions for glaucoma. SPECTRUM is a patient registry for the Hydrus® Microstent, a microinvasive glaucoma surgery (MIGS) device to treat patients with mild to moderate primary open-angle ...
-
Metrofocus
ADVANCEMENTS IN EYE CARE: FATHER-SON TEAM RESTORING SIGHT At the height of the pandemic, across most medical specialties, doctors noted a sharp drop in care as patients curbed nonessential visits and procedures out of the fear that a medical appointment could lead to the coronavirus infection. But it wasn’t just dramatic specialties like cancer or heart care that saw collateral damage from ...
-
FDA approval of clinical trial expansion of Prima System US feasibility study to Stanford Medicine
Paris, France, January 19, 2022 – 07:00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces today the approval by US FDA of the expansion of the Prima System* US feasibility study to include Stanford Medicine as a ...
-
Sight Sciences Receives FDA 510(k) Clearance of the TearCare System for Treatment of Meibomian Gland Dysfunction (MGD), the Leading Cause of Dry Eye Disease
Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the TearCare® System for the treatment of meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED). The indication ...
-
First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today the first-ever, four-year follow-up data for a MIGS device in an FDA pivotal trial. The latest findings from the HORIZON study confirm the benefits of the Hydrus Microstent seen in earlier follow-up and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you